HireQuest, Inc. (HQI) - Q2 2024 10-Q Summary
Business Context and Reporting Period
HireQuest, Inc. is a nationwide franchisor of staffing offices operating under brands including HireQuest Direct, Snelling, DriverQuest, and MRI. The company provides direct-dispatch, executive search, and commercial staffing solutions. This report covers the quarterly period ended June 30, 2024. As of this date, the company operated 413 franchisee-owned offices and 1 company-owned office across 43 states and 13 international countries.
Key Financial Metrics
| Metric (in thousands) | Q2 2024 (3 Months) | Q2 2023 (3 Months) | YTD 2024 (6 Months) | YTD 2023 (6 Months) |
|---|---|---|---|---|
| Total Revenue | $8,680 | $8,990 | $17,099 | $18,848 |
| Net Income | $2,039 | $2,008 | $3,658 | $4,638 |
| Operating Income | $2,695 | $2,665 | $4,797 | $5,981 |
| Adjusted EBITDA | $4,040 | $3,871 | $7,398 | $8,452 |
| Cash and Equivalents | $614 | $1,342 (Dec 31, 2023) | $614 | $2,071 (Jun 30, 2023) |
| Line of Credit Outstanding | $15,700 | $14,119 (Dec 31, 2023) | $15,700 | $14,119 (Dec 31, 2023) |
| System-Wide Sales | $146,133 | $156,966 | $280,177 | $310,484 |
Note: Revenue consists primarily of franchise royalties (94.5% of Q2 2024 revenue) and service revenue. Net income includes a loss of $36,000 from discontinued operations for Q2 2024.
Material Changes vs. Prior Period
- Revenue Decline: Total revenue decreased 3.4% in Q2 2024 and 9.3% YTD compared to the prior year. This was driven by a 6.9% decrease in system-wide sales, with significant declines in the MRI segment ($6.0M decrease in Q2 system-wide sales).
- Profitability: Despite lower revenue, Net Income increased slightly in Q2 2024 (+1.5%) due to cost reductions. Operating expenses decreased 5.4% in Q2, primarily due to an 8.9% reduction in headcount.
- Cash Flow: Net cash used in operating activities was $779,000 for the six months ended June 30, 2024, compared to $228,000 in the prior year period. This was largely due to a $5.65 million increase in accounts receivable.
- Debt Utilization: The company increased its line of credit draw to $15.7 million (from $14.1 million at year-end 2023) to fund operations and acquisitions. The effective interest rate on the line of credit was approximately 6.6%.
Outlook, Risks, and Contingencies
- Guidance: The filing does not provide specific numerical guidance for the full year 2024. Management expects to continue paying quarterly dividends ($0.06 per share).
- Internal Control Material Weakness: Management concluded that disclosure controls and procedures were not effective as of June 30, 2024, due to a material weakness in internal control over financial reporting. This stems from insufficient accounting resources to handle technical accounting issues and review functions. Remediation efforts include hiring a new CFO and additional accounting staff.
- Discontinued Operations: The company continues to market assets from the Dubin acquisition (Philadelphia location) and Dental Power (sold in 2023) as held-for-sale. These operations generated a net loss of $36,000 in Q2 2024.
- Risk Factors: Key risks include the financial performance of franchisees, workers' compensation claim volatility, and the impact of global economic conditions (inflation, geopolitical conflicts) on staffing demand.
Investor Verification Checklist
- Internal Control Remediation: Verify the progress of hiring and process changes to address the material weakness in financial reporting controls.
- System-Wide Sales Trend: Monitor the continued decline in MRI system-wide sales and its impact on royalty revenue.
- Liquidity Position: Assess the company's ability to maintain liquidity given the $0.6 million cash balance and $15.7 million line of credit draw, particularly with $5.7 million tied up in accounts receivable growth.
- Dividend Sustainability: Confirm the ability to maintain the $0.06 quarterly dividend given the cash burn from operations and working capital requirements.
- Discontinued Operations Sale: Track the status of the sale of the Dubin Philadelphia location assets, which remain held-for-sale.